Skip to content

This study aims to find out how well individually selected homoeopathic medicines, given in very small repeated doses (50 millesimal potency), work in reducing asthma symptoms in children, along with understanding their underlying health patterns

Effectiveness of individualized homoeopathic medicine in the treatment of childhood bronchial asthma using 50 millesimal potency: A prospective interventional study with miasmatic analysis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098011
Enrollment
50
Registered
2025-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Individualized Homoeopathic Medicine in 50 millesimal potency: indicated individualized homoeopathic medicine in 50 millesimal potency will be prescribed after detailed case taking and

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children who have been previously diagnosed with bronchial asthma or clinically diagnosed at the time of enrolment 2 Children of Age 6 to 11 years irrespective of their gender race religion and socio economic status 3 Patient whose parents are willing to provide written and or verbal assent 4 Patient whose parents are able to read and or understand Bengali or Hindi or English

Exclusion criteria

Exclusion criteria: 1 Children having congenital abnormalities 2 Cases requiring immediate surgical intervention or life support measures 3 Cases suffering from uncontrolled systemic illness or life-threatening infections 4 Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure 5 Undergoing homoeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

MeasureTime frame
The outcome assessment of the patients shall be calculated as per changes C ACT baseline and 6th month follow up Score will be calculated as a mean of the ratings given by the patients These are values between 0 to 27Timepoint: Baseline and 6th months

Secondary

MeasureTime frame
The outcome assessment of the patients shall be calculated as per changes in MONARCH baseline & 6th month follow up These are values between -6 to +13Timepoint: Baseline & 6 months

Countries

India

Contacts

Public ContactDr Gobind Narayan Gupta

National Institute of Homoeopathy

dr.gn05gupta@gmail.com9163197805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026